Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Type
Year of publication
Survey or statistical program
- Research and Development of Canadian Private Non-Profit Organizations (4)
- Provincial Government Activities in the Natural Sciences (4)
- Biotechnology Use and Development Survey (4)
- Scientific Activities of Provincial Research Organizations, Activities in Natural Sciences and Engineering (3)
- Scientific and Technological Activities of Provincial Governments (3)
- Federal Science Expenditures and Personnel, Activities in the Social Sciences and Natural Sciences (2)
- Higher Education Research and Development Estimates (2)
- Annual Survey of Research and Development in Canadian Industry (1)
Results
All (11)
All (11) (0 to 10 of 11 results)
- Journals and periodicals: 11-402-XGeography: CanadaDescription:
Presented in almanac style, the 2012 Canada Year Book contains more than 500 pages of tables, charts and succinct analytical articles on every major area of Statistics Canada's expertise. The Canada Year Book is the premier reference on the social and economic life of Canada and its citizens.
Release date: 2012-12-24 - 2. Estimates of total spending on research and development in the health field in Canada 1996 to 2007 ArchivedStats in brief: 88-001-X200800310651Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1996 to 2007 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.
Release date: 2008-07-22 - Articles and reports: 88-003-X200700210325Geography: CanadaDescription:
Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.
Release date: 2007-10-09 - 4. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey ArchivedArticles and reports: 88-003-X20070019620Geography: Canada, Province or territoryDescription:
Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.
Release date: 2007-05-10 - 5. Estimates of total spending on research and development in the health field in Canada, 1989 to 2006 ArchivedStats in brief: 88-001-X20070029607Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1989 to 2006 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.
Release date: 2007-03-30 - 6. Estimates of total spending on research and development in the health field in Canada, 1988 to 2005 ArchivedStats in brief: 88-001-X20060039191Description:
This service bulletin contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1988 to 2005 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD), are growing.
Release date: 2006-05-12 - Articles and reports: 88F0006X2005010Description:
This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.
Release date: 2005-04-29 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - Articles and reports: 88F0006X2004005Description:
This document presents the geographical distribution of federal government expenditures on science and technology. The statistics presented in this report are supplements of data published in the Service Bulletin 'Science Statistics' Volume 28, Number 3, Catalogue no. 88-001XIE.
Included in this report are tables presenting expenditures and staff of federal government scientific establishments for the fiscal year 2001/02.
Release date: 2004-02-12 - 10. Estimates of total spending on research and development in the health field in Canada, 1988 to 2000 ArchivedStats in brief: 88-001-X20010027920Description:
Canadian health research is conducted in universities, teaching hospitals, business enterprises, government laboratories and private non-profit organizations. This research is funded from a variety of sources including public, private, domestic and foreign.
Release date: 2001-03-30
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (11)
Analysis (11) (0 to 10 of 11 results)
- Journals and periodicals: 11-402-XGeography: CanadaDescription:
Presented in almanac style, the 2012 Canada Year Book contains more than 500 pages of tables, charts and succinct analytical articles on every major area of Statistics Canada's expertise. The Canada Year Book is the premier reference on the social and economic life of Canada and its citizens.
Release date: 2012-12-24 - 2. Estimates of total spending on research and development in the health field in Canada 1996 to 2007 ArchivedStats in brief: 88-001-X200800310651Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1996 to 2007 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.
Release date: 2008-07-22 - Articles and reports: 88-003-X200700210325Geography: CanadaDescription:
Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.
Release date: 2007-10-09 - 4. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey ArchivedArticles and reports: 88-003-X20070019620Geography: Canada, Province or territoryDescription:
Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.
Release date: 2007-05-10 - 5. Estimates of total spending on research and development in the health field in Canada, 1989 to 2006 ArchivedStats in brief: 88-001-X20070029607Geography: CanadaDescription:
This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1989 to 2006 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.
Release date: 2007-03-30 - 6. Estimates of total spending on research and development in the health field in Canada, 1988 to 2005 ArchivedStats in brief: 88-001-X20060039191Description:
This service bulletin contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1988 to 2005 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD), are growing.
Release date: 2006-05-12 - Articles and reports: 88F0006X2005010Description:
This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.
Release date: 2005-04-29 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - Articles and reports: 88F0006X2004005Description:
This document presents the geographical distribution of federal government expenditures on science and technology. The statistics presented in this report are supplements of data published in the Service Bulletin 'Science Statistics' Volume 28, Number 3, Catalogue no. 88-001XIE.
Included in this report are tables presenting expenditures and staff of federal government scientific establishments for the fiscal year 2001/02.
Release date: 2004-02-12 - 10. Estimates of total spending on research and development in the health field in Canada, 1988 to 2000 ArchivedStats in brief: 88-001-X20010027920Description:
Canadian health research is conducted in universities, teaching hospitals, business enterprises, government laboratories and private non-profit organizations. This research is funded from a variety of sources including public, private, domestic and foreign.
Release date: 2001-03-30
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: